Top pharma companies by prescription drug sales

People care about big pharma's actions — especially as the industry faces heightened political pressure to lower prescription drug prices and intensified scrutiny about pricing strategies. While the public knows many of the top dogs by name, there are other industry leaders to note when it comes to prescription drugs.

Below is a list of the top pharmaceutical companies worldwide based on prescription drug sales in 2017. Pharm Exec, which partnered with market intelligence firm Evaluate to collect the data, generated the list.  

Here are the 20 top pharma companies by prescription drug sales:

1. Pfizer — $45.35 billion

2. Novartis — $41.88 billion

3. Roche — $41.73 billion

4. Merck — $35.27 billion

5. Johnson & Johnson — $34.4 billion

6. Sanofi — $34.08 billion

7. GlaxoSmithKline — $28.67 billion

8. AbbVie — $27.75 billion

9. Gilead Sciences — $25.66 billion

10. Amgen —$21.8 billion

11. AstraZeneca — $19.78 billion

12. Bristol-Myers Squibb — $19.26 billion

13. Eli Lilly — $18.52 billion

14. Teva Pharmaceutical Industries — $18.26 billion

15. Bayer — $17.54 billion

16. Novo Nordisk — $16.97 billion

17. Allergan — $14.91 billion

18. Shire — $14.26 billion

19. Boehringer Ingelheim — $14.26 billion

20. Takeda — $13.58 billion

Read the full list here.

More articles on pharmacy: 
Allergan sues Pfizer over costs related to opioid lawsuits
Teva's revenue drops 18% in Q2
Who knew? There's a trophy for 'most hated' pharma chief: 10 notes

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months